Medical/Pharmaceuticals
MIM Software Celebrates MTIC's First Total-Body PET/CT Scanner
The Melbourne Theronastic Innovation Centre, in partnership with Siemens Healthineers and MIM Software, will provide patients with access to a platform that will facilitate faster prognosis and personalized therapy using the world's most sensitive whole-body PET/CT scanner. CLEVELAND, April 13, ...
2023-04-13 10:48
2639
Altair to Showcase Pharmaceutical Process Optimization Technology at the Korea Pharm&Bio 2023
Altair will feature pharmaceutical manufacturing process simulation and data analytics technologies SEONGNAM, South Korea, April 13, 2023 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), will be exhibiting at Korea Pharm&Bio,April ...
2023-04-13 08:00
4363
LBB Specialties Announces Senior Vice President for Life Sciences
NORWALK, Conn., April 12, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredients distribution in North America, announced Seth Burns has joined LBB Specialties as Senior Vice President, Life Sciences. In his new role, Burns will be responsible for establishing...
2023-04-12 22:45
3030
NCCN Annual Conference Brings Up Important Questions for Improving Cancer Care
National Comprehensive Cancer Network's yearly conference for interdisciplinary healthcare providers focused on applying the latest evidence-based recommendations and fostering welcoming environments for patients and staff that lead to better treatment, outcomes, and quality-of-life for people wi...
2023-04-12 22:16
2911
Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program
Study commences following green light from the U.S. FDA for Investigational New Drug Application HONG KONG, GERMANTOWN, Md. and SUZHOU, China, April 12, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the"Group" or "Sirnaomics"), a leadin...
2023-04-12 16:25
4240
WORLD BRAIN DAY 2023: PUTTING A SPOTLIGHT ON BRAIN HEALTH AND DISABILITY
LONDON, April 11, 2023 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announceBrain Health and Disability as the theme for its 10th Annual World Brain Day (WBD) onSaturday, July 22. This year's theme will inspire a global initiative to close the gaps in disability awareness...
2023-04-11 21:20
3248
DISCOVERY LIFE SCIENCES ACQUIRES REACHBIO RESEARCH LABS
Acquisition to enhance cell biology capabilities and accelerate assessments of potential new drug targets HUNTSVILLE, Ala., April 11, 2023 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has acquired Seattle -basedReachBio Research Labs (ReachBio...
2023-04-11 21:05
4610
Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market
Inotiv offers fit-for-purpose drug testing approaches and quality-by-design methodologies to facilitate sample analysis accuracy, boosting clients' success rates. SAN ANTONIO, April 11, 2023 /PRNewswire/ -- Recently, Frost & Sullivan assessed the bio-analytical testing services industry and, bas...
2023-04-11 21:00
4053
Boan Biotech's Biologics License Application for Boyounuo® (Bevacizumab Injection) Accepted in Brazil
YANTAI, China, April 11, 2023 /PRNewswire/ -- Boan Biotech today announced that Brazil's Agência Nacional de Vigilância Sanitária (ANVISA) has accepted the company's Biologics License Application (BLA) for Boyounuo® (Bevacizumab Injection). Envisioned to be "a leading global biopharmaceutical co...
2023-04-11 20:19
5452
ACM Biolabs Further Strengthens Leadership, Appoints David Lawrence to Board of Directors
SINGAPORE, April 11, 2023 /PRNewswire/ -- ACM Biolabs (FR0012596468 – ALSEN) a pioneering Singaporean-Swiss biotechnology company, which specializes in the development of targeted therapeutics for the prevention of multiple life-threatening diseases based on its proprietary ACM (Artificial Cell ...
2023-04-11 19:00
3231
Biosyngen received China NMPA IND approval for its T-cell redirection therapy targeting EBV-positive Lymphoma
GUANGZHOU, China, April 11, 2023 /PRNewswire/ -- April 7th, 2023, Biosyngen Pte Ltd (hereinafter as "Biosyngen") was granted IND approval by China NMPA for the company's first-in-class T-cell redirection therapy, it is an autologous T cell therapy for EBV-positive lymphoma. The principle of autol...
2023-04-11 18:09
3952
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
LEIDEN, Netherlands, April 11, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commercial shipments of Joenja® (leniolisib) to patients inthe United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only trea...
2023-04-11 13:00
3818
When Blood Is a New Alternative Medicine for Pain Relief at Chula Pain Clinic
BANGKOK, April 11, 2023 /PRNewswire/ -- Chula Medicine researchers have successfully published an article on the injection of patient's own platelets rich plasma into the shoulderligaments resulting in pain reduction, heal torn ligaments and restore torn muscles as an alternative to surgery while...
2023-04-11 09:00
3399
Smith+Nephew signs exclusive distribution agreement to bring unique NAVBIT SPRINT™ solution for accurate acetabular cup alignment to Japan
Small, disposable, compact and simple to use navigation tool offers surgeons speed and reliability without the financial burden of capital equipment LONDON, April 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces an agreement with NAV...
2023-04-11 07:00
4752
Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate
MELBOURNE, Australia, April 11, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a Phase I study of TLX101 investigational therapy (4-L-[131I]...
2023-04-11 05:00
3255
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES RESIDENCY AT JLABS @ SHANGHAI
SINGAPORE, April 10, 2023 /PRNewswire/ -- Respiree announced today that it has
become a resident ofJohnson & Johnson Innovation – JLABS @ Shanghai ('JLABS')
2023-04-10 20:10
4366
JW Therapeutics Announces IND Approval for the Clinical Trial of Relma-cel in Patients with Moderately or Severely Refractory Systemic Lupus Erythematosus
SHANGHAI, April 10, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that it has received the Investigational New Drug (IND) clearance from the Na...
2023-04-10 19:30
5107
HistoIndex embarks on partnership with VCU's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health in the study of liver diseases
Advancing ML/AI-based technology in the study of liver diseases by furthering strategic partnerships using a stain-free digital pathology system. SINGAPORE, April 10, 2023 /PRNewswire/ -- Virginia Commonwealth University's Stravitz-Sanyal Institute for Liver Disease and Metabolic Health has annou...
2023-04-10 19:00
3804
Chula Launches the Latest Parkinson's Gloves to Reduce Tremors
Doctors at King Chulalongkorn Memorial Hospital have developed lightweight and easy-to-use Parkinson's gloves that can automatically reduce tremors, allowing Parkinson's Disease patients to enjoy social life and reducing side effects from medication and risk from brain surgery. BANGKOK, April 10...
2023-04-10 09:30
4850
Cooperation Agreement Concluded between BioKangtai and Biotis
-- Indicating Technology Transfer of the World's First Dual-carrier 13-valent Pneumococcal Conjugate Vaccine toIndonesia SHENZHEN, China, April 7, 2023 /PRNewswire/ -- On the morning of April 5, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as "BioMinhai"), a wholly-owned subsi...
2023-04-07 10:41
5468
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 270 media titles]
2026-10-14 18:01Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
16726
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
16655
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
2026-10-13 10:00
14362
Zoomlion Expands Mining Machinery Business as International Revenue Grows
2026-10-10 16:58
8354
